CID 10302451

Saracatinib

Structural Information

Molecular Formula
C27H32ClN5O5
SMILES
CN1CCN(CC1)CCOC2=CC3=C(C(=C2)OC4CCOCC4)C(=NC=N3)NC5=C(C=CC6=C5OCO6)Cl
InChI
InChI=1S/C27H32ClN5O5/c1-32-6-8-33(9-7-32)10-13-35-19-14-21-24(23(15-19)38-18-4-11-34-12-5-18)27(30-16-29-21)31-25-20(28)2-3-22-26(25)37-17-36-22/h2-3,14-16,18H,4-13,17H2,1H3,(H,29,30,31)
InChIKey
OUKYUETWWIPKQR-UHFFFAOYSA-N
Compound name
N-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-(oxan-4-yloxy)quinazolin-4-amine
Related CIDs

2D Structure

compound 2d structure
5
Annotation Hits

221
References

7390
Patents

541.20917 Da
Monoisotopic Mass

4.1
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 542.21645 228.6
[M+Na]+ 564.19839 231.8
[M-H]- 540.20189 237.1
[M+NH4]+ 559.24299 226.8
[M+K]+ 580.17233 228.8
[M+H-H2O]+ 524.20643 213.9
[M+HCOO]- 586.20737 229.4
[M+CH3COO]- 600.22302 232.4
[M+Na-2H]- 562.18384 225.9
[M]+ 541.20862 229.2
[M]- 541.20972 229.2
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe